Serum microRNA as indicators of Wolfram syndrome's progression in neuroimaging studies.
Agnieszka ZmyslowskaMarcin StanczakZuzanna NowickaArleta WaszczykowskaDobromila BaranskaWojciech FendlerMaciej BorowiecWojciech MłynarskiPublished in: BMJ open diabetes research & care (2021)
Our findings show for the first time that serum miRNAs can be used as easily accessible indicators of disease progression in patients with WFS, potentially facilitating clinical trials on mitigating neurodegeneration.